Home › Companies › PRAXIS PRECISION MEDICINES INC. › 2024-2025
Compiled from SEC Form N-PX filings and PRAXIS PRECISION MEDICINES INC.’s Form 8-K, filed 2025-06-27 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Proxy season: 2024-2025 2025-2026
Explore PRAXIS PRECISION MEDICINES INC. in the interactive database Compare manager voting policies
These tallies are PRAXIS PRECISION MEDICINES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-27 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Jeffrey Chodakewitz, M.D. | 14,596,188 | -- | -- | 2,998,186 | 778,152 | Majority: yes |
| Elect Director: Merit Cudkowicz, M.D. | 17,499,300 | -- | -- | 95,074 | 778,152 | Majority: yes |
| Proposal 2: Ratification of Appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm | 18,358,636 | 7,630 | 6,260 | -- | 0 | Majority: yes |
| Proposal 3: Advisory Vote on Executive Compensation The Company's stockholders approved, on an advisory (non-binding) basis, the compensation of the Company's named executive officers, with the votes cast as follows: | 10,671,320 | 6,919,705 | 3,349 | -- | 778,152 | Majority: yes |
Source: PRAXIS PRECISION MEDICINES INC., Form 8-K, filed with the SEC on 2025-06-27 — read the filing on EDGAR.
Each item below shows how the 185 asset managers that disclosed a PRAXIS PRECISION MEDICINES INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 9 wordings of this item as funds reported it.
61% Majority: yes · of votes cast
PRAXIS PRECISION MEDICINES INC.’s own tally for this item (“Proposal 3: Advisory Vote on Executive Compensation The Company's stockholders approved, on an advisory (non-binding) basis, the compensation of the Company's named executive officers, with the votes cast as follows:”): 10,671,320 for, 6,919,705 against, per its Form 8-K filed 2025-06-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 20,341,917 outstanding shares: 52.5% for, 34% against (86% of the company cast a for/against vote).
The 184 asset managers below cast 57% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 0 | 2,111,118 | 0 | 0 | Against |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,914,591 | 0 | 0 | 0 | For |
| Janus Henderson | 1,431,878 | 34,015 | 0 | 0 | For |
| Cormorant Asset Management, LP | 1,446,372 | 0 | 0 | 0 | For |
| Soleus Capital Management, L.P. | 1,249,740 | 0 | 0 | 0 | For |
| Vanguard | 0 | 1,096,143 | 0 | 0 | Against |
| PERCEPTIVE ADVISORS LLC | 1,093,950 | 0 | 0 | 0 | For |
| BlackRock | 28,955 | 914,331 | 0 | 0 | Against |
| State Street | 856,181 | 7,725 | 0 | 0 | For |
| BAKER BROS. ADVISORS LP | 689,488 | 0 | 0 | 0 | For |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 686,931 | 0 | 0 | 0 | For |
| Fidelity | 0 | 433,869 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 403,082 | 0 | 0 | Against |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 397,994 | 0 | 0 | 0 | For |
| Point72 | 0 | 370,817 | 0 | 0 | Against |
| CIBC Asset Management Inc | 0 | 336,392 | 0 | 0 | Against |
| FRANKLIN ADVISERS INC | 0 | 314,103 | 0 | 0 | Against |
| Aberdeen | 0 | 301,382 | 0 | 0 | Against |
| Charles Schwab | 0 | 285,890 | 0 | 0 | Against |
| VR Adviser, LLC | 244,858 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 234,406 | 0 | 0 | 0 | For |
| Verition Fund Management LLC | 0 | 199,642 | 0 | 0 | Against |
| Northern Trust | 0 | 191,334 | 0 | 0 | Against |
| 5AM Venture Management, LLC | 170,000 | 0 | 0 | 0 | For |
| PFM Health Sciences, LP | 0 | 126,025 | 0 | 0 | Against |
Showing the 25 largest of 184 asset managers. See all 184 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
PRAXIS PRECISION MEDICINES INC.’s own tally for this item (“Proposal 2: Ratification of Appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's indepe”): 18,358,636 for, 7,630 against, per its Form 8-K filed 2025-06-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 20,341,917 outstanding shares: 90% for, 0.1% against (90% of the company cast a for/against vote).
The 52 asset managers below cast 100% of the shares they voted on this item FOR (4,187,945 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,053,731 | 0 | 0 | 0 | For |
| T. Rowe Price | 905,205 | 0 | 0 | 0 | For |
| BlackRock | 452,758 | 0 | 0 | 0 | For |
| Fidelity | 397,267 | 0 | 0 | 0 | For |
| State Street | 277,260 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 234,406 | 0 | 0 | 0 | For |
| Aberdeen | 150,691 | 0 | 0 | 0 | For |
| Charles Schwab | 142,945 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 113,704 | 0 | 0 | 0 | For |
| Northern Trust | 62,824 | 0 | 0 | 0 | For |
| Equitable | 53,477 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 44,110 | 0 | 0 | 0 | For |
| TIAA | 43,460 | 0 | 0 | 0 | For |
| Brighthouse | 41,344 | 0 | 1,670 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 25,976 | 0 | 0 | 0 | For |
| Transamerica | 20,311 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 19,393 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 14,808 | 0 | 0 | 0 | For |
| Lincoln Financial | 12,800 | 0 | 0 | 0 | For |
| John Hancock | 11,969 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 11,037 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 10,500 | 0 | 0 | 0 | For |
| Global X | 10,448 | 0 | 0 | 0 | For |
| UBS | 10,400 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 10,256 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Combines 3 wordings of this item as funds reported it.
83% Majority: yes · of votes cast
PRAXIS PRECISION MEDICINES INC.’s own tally for this item (“Elect Director: Jeffrey Chodakewitz, M.D.”): 14,596,188 for, 2,998,186 withheld, per its Form 8-K filed 2025-06-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 20,341,917 outstanding shares: 72% for, 15% withheld (86% of the company cast a for/withheld vote).
The 51 asset managers below cast 100% of the shares they voted on this item FOR (3,712,298 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,053,731 | 0 | 0 | 0 | For |
| T. Rowe Price | 905,205 | 0 | 0 | 0 | For |
| BlackRock | 452,758 | 0 | 0 | 0 | For |
| Fidelity | 361,398 | 0 | 35,869 | 0 | For |
| State Street | 276,907 | 0 | 353 | 0 | For |
| JANUS INVESTMENT FUND | 234,406 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 0 | 150,691 | 0 | Abstain |
| Charles Schwab | 142,945 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 0 | 0 | 113,704 | 0 | Abstain |
| Northern Trust | 0 | 0 | 62,824 | 0 | Abstain |
| Equitable | 35,437 | 0 | 18,040 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 44,110 | 0 | 0 | 0 | For |
| TIAA | 43,460 | 0 | 0 | 0 | For |
| Brighthouse | 35,092 | 0 | 7,922 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 25,976 | 0 | 0 | 0 | For |
| Transamerica | 20,311 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 19,393 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 0 | 0 | 14,808 | 0 | Abstain |
| Lincoln Financial | 12,800 | 0 | 0 | 0 | For |
| John Hancock | 5,832 | 0 | 6,137 | 0 | Abstain |
| Direxion Shares ETF Trust | 0 | 0 | 11,037 | 0 | Abstain |
| HUSSMAN INVESTMENT TRUST | 10,500 | 0 | 0 | 0 | For |
| Global X | 0 | 0 | 10,448 | 0 | Abstain |
| UBS | 0 | 0 | 10,400 | 0 | Abstain |
| Brinker Capital Destinations Trust | 10,256 | 0 | 0 | 0 | For |
Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.4% Majority: yes · of votes cast
PRAXIS PRECISION MEDICINES INC.’s own tally for this item (“Elect Director: Merit Cudkowicz, M.D.”): 17,499,300 for, 95,074 withheld, per its Form 8-K filed 2025-06-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 20,341,917 outstanding shares: 86% for, 0.5% withheld (86% of the company cast a for/withheld vote).
The 51 asset managers below cast 100% of the shares they voted on this item FOR (4,150,190 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,053,731 | 0 | 0 | 0 | For |
| T. Rowe Price | 905,205 | 0 | 0 | 0 | For |
| BlackRock | 452,758 | 0 | 0 | 0 | For |
| Fidelity | 361,398 | 0 | 35,869 | 0 | For |
| State Street | 277,260 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 234,406 | 0 | 0 | 0 | For |
| Aberdeen | 150,691 | 0 | 0 | 0 | For |
| Charles Schwab | 142,945 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 113,704 | 0 | 0 | 0 | For |
| Northern Trust | 62,824 | 0 | 0 | 0 | For |
| Equitable | 53,477 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 44,110 | 0 | 0 | 0 | For |
| TIAA | 43,460 | 0 | 0 | 0 | For |
| Brighthouse | 41,344 | 0 | 1,670 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 25,976 | 0 | 0 | 0 | For |
| Transamerica | 20,311 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 19,393 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 14,808 | 0 | 0 | 0 | For |
| Lincoln Financial | 12,800 | 0 | 0 | 0 | For |
| John Hancock | 11,969 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 11,037 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 10,500 | 0 | 0 | 0 | For |
| Global X | 10,448 | 0 | 0 | 0 | For |
| UBS | 10,400 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 10,256 | 0 | 0 | 0 | For |
Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.
Ranked by the number of PRAXIS PRECISION MEDICINES INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 20,341,917 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | T. Rowe Price | 10.38% |
| 2 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 9.41% |
| 3 | Janus Henderson | 7.21% |
| 4 | Cormorant Asset Management, LP | 7.11% |
| 5 | Soleus Capital Management, L.P. | 6.14% |
| 6 | Vanguard | 5.39% |
| 7 | PERCEPTIVE ADVISORS LLC | 5.38% |
| 8 | BlackRock | 4.64% |
| 9 | State Street | 4.25% |
| 10 | BAKER BROS. ADVISORS LP | 3.39% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 13.59% | 13G |
| ORBIS INVESTMENT MANAGEMENT LTD | 12.13% | 13G |
| FMR LLC | 10.60% | 13G |
| Perceptive Advisors LLC | 9.81% | 13G |
| Entities affiliated with Perceptive Advisors | 8.99% | DEF14A |
| Baker Bros. Advisors LP | 8.62% | 13G |
| BlackRock | 6.97% | 13F |
| Entities affiliated with Point72 | 6.14% | DEF14A |
| Morgan Stanley | 5.97% | 13F |
| Steven A. Cohen | 5.96% | 13G |
Percentages above are of 20,341,917 shares outstanding, as reported by PRAXIS PRECISION MEDICINES INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from PRAXIS PRECISION MEDICINES INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At PRAXIS PRECISION MEDICINES INC.'s shareholder meeting held 2025-06-26, in the 2024-2025 proxy season, 185 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 775 separate fund positions. On the most widely held item on that ballot — TO APPROVE, ON AN ADVISORY (NON-BINDING) BASIS, THE COMPENSATION OF THE NAMED EXECUTIVE… — FOR was 61% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: PRAXIS PRECISION MEDICINES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-06-27.
PRAXIS PRECISION MEDICINES INC. proxy season coverage: 2024-2025 (this page) · 2025-2026.